Emerging Advances in Gastrointestinal Cancers | Supplements And Featured Publications

Talking HER2-Targeted Therapy With Dr. Ajani

April 04, 2020

We had the pleasure of speaking with Jaffer Ajani, MD, who discussed some of the investigational HER2-targeted treatment strategies with trastuzumab, antibody-drug conjugates, and bispecific antibodies that are under investigation in gastrointestinal malignancies.